
Exhar Formulations Private Limited
Veterinary medicine trading for domestic market, manufacturing, importing, exporting, and distributing pharmaceutical and healthcare products.
Veterinary medicine trading for domestic market, manufacturing, importing, exporting, and distributing pharmaceutical and healthcare products.
Exhar Formulations Private Limited (EFPL) is a Private Limited Indian Non-Government Company incorporated in India on 13 April 2007 and has a history of 18 years. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company has closed loans amounting to ₹3.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Anandam Sinha, Rajeev Kumar, Rakesh Sinha, and Three other members serve as directors at the Company.
Delhi, India
+91-XXXXXXXXXX
U51511DL2007PTC162025
162025
Private Limited Indian Non-Government Company
13 Apr 2007
30 Sep 2023
31 Mar 2023
Unlisted
Roc Delhi
Name | Designation | Appointment Date | Status |
---|---|---|---|
Anandam Sinha ![]() | Director | 13-Apr-2007 | Current |
Rajeev Kumar ![]() | Director | 13-Apr-2007 | Current |
Rakesh Sinha ![]() | Additional Director | 01-Jul-2009 | Current |
Meeta Sinha ![]() | Additional Director | 01-Jul-2009 | Current |
Binay Kumar ![]() | Additional Director | 01-Jul-2009 | Current |
Rajiv Kumar ![]() | Additional Director | 01-Jul-2009 | Current |
Exhar Formulations Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 40.41% increase. The company also saw a substantial improvement in profitability, with a 29.17% increase in profit. The company's net worth Soared by an impressive increase of 37.85%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2018, Exhar Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Anandam Sinha, Rajeev Kumar and 4 more are mutual person
Meeta Sinha is a mutual person
₹0
₹3.00 M
Date | Lender | Amount | Status |
---|---|---|---|
04 Jul 2019 | Others | ₹3.00 M | Satisfied |
Exhar Formulations has a workforce of 9 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Exhar Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Exhar Formulations's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Exhar Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Exhar Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi.
A charge registered on 04 Jul 2019 via Charge ID 100280785 with Others was fully satisfied on 07 Jan 2021.
A charge with Others amounted to Rs. 3.00 M with Charge ID 100280785 was registered on 04 Jul 2019.
Rakesh Sinha was appointed as a Additional Director was appointed as a Additional Director on 01 Jul 2009 & has been associated with this company since 15 years 9 months .
Meeta Sinha was appointed as a Additional Director was appointed as a Additional Director on 01 Jul 2009 & has been associated with this company since 15 years 9 months .
Exhar Formulations Private Limited was incorporated on 13 Apr 2007.
The authorized share capital of Exhar Formulations Private Limited is ₹ 0.50 M and paid-up capital is ₹ 0.50 M.
Currently 6 directors are associated with Exhar Formulations Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Exhar Formulations Private Limited is Shop No 364 Third Floor Vardhman Crown Mall Plot 2 Sector 19 Dwarka India, New Delhi, 110075.
The corporate identification number (CIN) of Exhar Formulations Private Limited is U51511DL2007PTC162025 and the company number is 162025 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2019, the revenue trend for Exhar Formulations Private Limited has risen by 40.41%.
As Per 2019 financial reports, 9 employees are currently employed by Exhar Formulations Private Limited.
The financial reports for the fiscal year 2019 indicates that The net worth of Exhar Formulations Private Limited has experienced an upsurge of 37.85%.
The most recent Balance Sheet for Exhar Formulations Private Limited was filed with the ROC on 31 Mar 2023.
Search company & director profiles for free and gain access to critical business data.